Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Podcasts

Effective May 1st, Podcasts will be an exclusive feature for Orthopedics This Week subscribers only.  So, go to our ‘Subscribe Now’ button and ensure un-interrupted access to Orthopedics This Week’s podcasts and all the benefits of an Orthopedics This Week subscription.

This Week

The Case of Brazil’s “Prosthetic Mafia”

A private Brazilian insurance group claims U.S. orthopedic and other implant device makers and the U.S. government allegedly violated the Foreign Corruption Act. In numerous private lawsuits, the group alleges a “Prosthetic Mafia” gorged payers.

The $1,000 Infection Tax

In this new era of cost containment in medicine, adding over $1,000 to the cost of a procedure sounds fiscally irresponsible. A group of new studies about post op infection rates provide new insights into this critical issue as contributing commentator, Jay Mabrey, M.D., MBA, CPE explains.

New Evidence: Mild Concussions Related to ALS

A new concussion model developed by Gretchen Thomsen, Ph.D., of the Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles and colleagues triggered earlier onset of familial Amyotrophic Lateral Sclerosis symptoms. The researchers hope that the model can be used to develop novel therapies.

12 Leading North American Hand Surgeons

According to their colleagues, these are the leading orthopedic hand surgeons in North America. Whether handling the wrist, elbow, or hand, these exemplary physicians have reached the pinnacle of their profession.

Most Popular

The Case of Brazil’s “Prosthetic Mafia”

A private Brazilian insurance group claims U.S. orthopedic and other implant device makers and the U.S. government allegedly violated the Foreign Corruption Act. In numerous private lawsuits, the group alleges a “Prosthetic Mafia” gorged payers.

12 Leading North American Hand Surgeons

According to their colleagues, these are the leading orthopedic hand surgeons in North America. Whether handling the wrist, elbow, or hand, these exemplary physicians have reached the pinnacle of their profession.

Judge Backs DOJ Effort to Stop Aetna-Humana Merger

Seven months after the DOJ filed a lawsuit to stop the $37B Aetna-Humana merger, along with a complementary Anthem-Cigna merger, a district judge rules in favor of the DOJ—but Aetna promises a quick appeal. What does a potential merger mean for the millions of Medicare Advantage customers who rely on these mega insurers for coverage?

10 Surprising 2017 Shoulder and Foot/Ankle Market Insights

Which companies will increase shoulder and foot/ankle market share in 2017. In mid-December we received a flashlight into the opaque future of those two dynamic extremity markets. The early Xmas gift came courtesy of top global medical technology analyst, Glenn Novarro. Here is what we learned.

The Ten Best New Spine Technologies for 2016

Robots, 3D printing and clever strategies for navigating the spinal anatomy dominated this year’s winning technologies. Clearly we are in an environment where risk reduction rules. And so our panel selected impressively clever technologies which make every surgeon even more perfect…and awesome. Congratulations to each and every winner!

Jones v. Berend: The Tourniquetless TKA: Let It Bleed

To tourniquet or to not tourniquet, that is the question. Dickey Jones says “Let it Bleed”. Keith Berend fights mightily to defend a near defenseless position. But at the end of the day, the winner, it seems, is tranexamic acid. Get ready to read one of the most unusual CCJR debates yet. Have fun folks.

Did Zimmer Biomet Just Pull a ‘Soft’ Turn With Vanguard?

The hype surrounding Zimmer Biomet’s Vanguard ID had us double checking with our surgeon friends. They told us this is actually a particularly interesting innovation in total knee arthroplasty. Apparently, the venerable Vanguard knee is still capable of a few new tricks. Here’s what we learned.

With 1.2 Million Medical Marijuana Users, Orthopods in Crosshairs

Medical marijuana is the law in 23 states, 1.2 million marijuana cards have been issued and the two most common reasons for getting a medical marijuana card are back and arthritis pain. How should orthopedists in those states deal with the phenomenon of medical marijuana? We have some answers.

Thienpont v. Ranawat—UKA: The Gold Standard for Medial Compartment Disease

Unicompartmental Knee or Total Knee? What’s not to like about preserving natural kinematics, lower infection rate and good post op range of motion? But can the patient live with higher revision rates? Dr. Thienpont argues for Uni while Dr. Ranawat takes the counter position. Great and timely debate this week.

OTW Presents
The Great CCJR Debates

Flatow v Seitz: Optimal Glenoid Fixation Requires Cement

Excellent debate this week. While both debaters agree that metal backed shoulder implants fail, the battle lines are clearly drawn when it comes to uncemented tantalum versus cemented poly. Evan Flatow and Bill Seitz give us an outstanding debate and review this week with Thomas Thornhill moderating.

Lewallen v. Hofmann: The Cemented All-Poly Tibia: An Affordable Care Act Solution

All-poly tibia is a very cost effective alternative and, says David Lewallen, M.D., should be part of every knee surgeon’s armamentarium. BUT, newer modular designs and metal backed trays give today’s surgeon more versatility, counters Aaron Hofmann, M.D. This is an essential debate and a must read for every orthopod.

Lonner v. Haas: Patella Resurfacing: Rarely if Ever Necessary

This week’s Orthopaedic Crossfire® debate tackles the sometimes contentious subject of patella resurfacing. Jess Lonner says it is rarely, if ever, necessary. Steven Haas finds a slew of meta studies that say otherwise. Who wins? You be the judge.

Jones v. Berend: The Tourniquetless TKA: Let It Bleed

To tourniquet or to not tourniquet, that is the question. Dickey Jones says “Let it Bleed”. Keith Berend fights mightily to defend a near defenseless position. But at the end of the day, the winner, it seems, is tranexamic acid. Get ready to read one of the most unusual CCJR debates yet. Have fun folks.

The Use of Stems in Complex Primary TKA: Necessary & Sufficient

To stem or not to stem, that is the question when faced with a specifically complex primary or revision knee arthroplasty because of deformity or instability. New Zealander Kelly Vince gives the pro-stem case while HSS’ Thomas Sculco shows himself to be a stem-less kind of guy. Who wins? The reader. Another truly excellent and informative debate from CCJR.

Gehrke v. Haidukewych: Mega Prosthesis for Distal Femoral Peri-Prosthetic Fx’s

OK, it’s a distal femoral peri-prosthetic fracture. Do you reach for the locking plates, the screws or the intramedullary nails? Or do you opt for a mega prosthesis? This week’s Orthopaedic Crossfire® debate tackles this excellent subject with ENDO-Klinik’s Gehrke choosing the big implant and Orlando Health’s Haidukewych going ORIF. Who wins? You judge.

Thienpont v. Ranawat—UKA: The Gold Standard for Medial Compartment Disease

Unicompartmental Knee or Total Knee? What’s not to like about preserving natural kinematics, lower infection rate and good post op range of motion? But can the patient live with higher revision rates? Dr. Thienpont argues for Uni while Dr. Ranawat takes the counter position. Great and timely debate this week.

Berend v. Dunbar: Outpatient TJA: “Drive-Thru” Surgery

Same day total knee arthroplasty is the siren song of large joint reconstruction. Michael Berend has performed over 2, 000 knee arthroplasties with 98% of these folks going home the same day and recommends it strongly. Michael Dunbar points out that these are select patients in a tightly controlled environment. Hard to duplicate especially with heavier, more diabetic and older patients. Read this very interesting debate here.

Lee v. Schmalzried: Ceramic-Ceramic THA in Patients <60: A New Standard

Is the use of ceramic-on-ceramic in young patients the new standard of care? Yes, says Lee. In fact c-on-c has better wear, is more reliable and provides more options. Not so fast says Schmalzried. Survivorship and function are no better, there is a squeaking and fracture risk. Who wins this debate? You be the judge.

Hozack v. Haddad: The Anterior Approach: Better, Faster, Cheaper

Anterior hip arthroplasty. Is it really better, faster and cheaper or is that mere marketing hype? This week’s debate pits William J. Hozack, M.D. against Fares Haddad, M.B., F.R.C.S. with Paul Lachiewicz moderating on this hot topic. Who wins this most entertaining debate? You be the judge.